<?xml version="1.0" encoding="UTF-8"?>
<p>The 15 experimental combinations (
 <xref rid="t0002" ref-type="table">Table 2</xref>) established in the DOE for the development of topical 4-MU formulation were applied to the dorsal skin of male and female 6- to 10-week-old WT C57BL/6J mice. HA ELISA-like assay was performed on harvested skin samples from those mice (normalized to total protein in the skin), and results for each condition are shown in 
 <xref rid="t0004" ref-type="table">Table 4</xref>.
</p>
